Results 201 to 210 of about 492,732 (252)
Extended-release Hydrocortisone Formulations-Is There a Clinically Meaningful Benefit?
J Clin Endocrinol MetabSteintorsdottir SD +3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
CNS Drugs, 2006
Galantamine inhibits acetylcholinesterase (AChE) to slow acetylcholine hydrolysis, and may also modulate presynaptic nicotinic receptor activation, thereby increasing neurotransmitter concentrations in the synaptic cleft.black triangle Once-daily galantamine extended release (ER) 24 mg and twice-daily galantamine immediate release (IR) 12 mg are ...
Dean M, Robinson, Greg L, Plosker
+5 more sources
Galantamine inhibits acetylcholinesterase (AChE) to slow acetylcholine hydrolysis, and may also modulate presynaptic nicotinic receptor activation, thereby increasing neurotransmitter concentrations in the synaptic cleft.black triangle Once-daily galantamine extended release (ER) 24 mg and twice-daily galantamine immediate release (IR) 12 mg are ...
Dean M, Robinson, Greg L, Plosker
+5 more sources
Drugs & Aging, 2000
Extended-release oxybutynin (Ditropan XL) uses an osmotic system (OROS) to deliver a controlled amount of oxybutynin chloride into the gastrointestinal tract over a 24-hour period when taken once daily. Oxybutynin binds to M3 muscarinic receptors on the detrusor muscle of the bladder, preventing acetylcholinergic activation and relaxing the muscle ...
A M, Comer, K L, Goa
+5 more sources
Extended-release oxybutynin (Ditropan XL) uses an osmotic system (OROS) to deliver a controlled amount of oxybutynin chloride into the gastrointestinal tract over a 24-hour period when taken once daily. Oxybutynin binds to M3 muscarinic receptors on the detrusor muscle of the bladder, preventing acetylcholinergic activation and relaxing the muscle ...
A M, Comer, K L, Goa
+5 more sources
CNS Drugs, 2006
Zolpidem extended-release, or controlled-release (CR), is a new formulation of zolpidem, a nonbenzodiazepine hypnotic. It is indicated in the US for the treatment of insomnia, characterised by difficulties with sleep onset and/or sleep maintenance. Zolpidem CR is a dual-layered tablet; one layer releases zolpidem immediately and a second layer provides
Marit D, Moen, Greg L, Plosker
+5 more sources
Zolpidem extended-release, or controlled-release (CR), is a new formulation of zolpidem, a nonbenzodiazepine hypnotic. It is indicated in the US for the treatment of insomnia, characterised by difficulties with sleep onset and/or sleep maintenance. Zolpidem CR is a dual-layered tablet; one layer releases zolpidem immediately and a second layer provides
Marit D, Moen, Greg L, Plosker
+5 more sources
CNS Drugs, 2007
Paliperidone extended release (ER) is an atypical antipsychotic that is administered orally once daily to provide consistent plasma drug concentrations over 24 hours in adult patients with schizophrenia. In four well controlled trials, once-daily administration of paliperidone ER 3-12 mg over 6 weeks was more effective than placebo in reducing the ...
Lily P H, Yang, Greg L, Plosker
+5 more sources
Paliperidone extended release (ER) is an atypical antipsychotic that is administered orally once daily to provide consistent plasma drug concentrations over 24 hours in adult patients with schizophrenia. In four well controlled trials, once-daily administration of paliperidone ER 3-12 mg over 6 weeks was more effective than placebo in reducing the ...
Lily P H, Yang, Greg L, Plosker
+5 more sources
Desvenlafaxine Extended Release
CNS Drugs, 2008▴ Desvenlafaxine extended release (ER) is a once-daily selective serotonin-noradrenaline (norepinephrine) reuptake inhibitor approved in the US for the treatment of major depressive disorder in adult patients. ▴ In two of three well designed, 8-week clinical trials, desvenlafaxine ER 50 mg/day (the recommended dosage) significantly improved depression ...
Lily P H, Yang, Greg L, Plosker
openaire +2 more sources